Table 2
Invasive Cancer Incidence by Primary Site and Age at Diagnosis
Michigan Residents, 2013

Primary Site
  (ICD-O-3 Cancer Incidence
Site Groupings)
 
Total Less than 50 Years 50 - 74 Years 75 Years & Over
Number Age-
Adjusted
Rate
Number Age-
Specific
Rate
Number Age-
Specific
Rate
Number Age-
Specific
Rate
Gastrointestinal Tract
& Digestive System
10,367 86.5 ±1.6 913 14.4 ±0.9 6,222 212.6 ±5.1 3,232 495.8 ±16.1
Lip, Oral Cavity & Pharynx 1,341 11.1 ±0.6 175 2.8 ±0.4 915 31.3 ±2.0 251 38.5 ±4.7
Stomach 749 6.3 ±0.4 57 0.9 ±0.2 416 14.2 ±1.4 276 42.3 ±5.0
Colon 3,116 26.5 ±0.9 267 4.2 ±0.5 1,631 55.7 ±2.7 1,218 186.9 ±10.3
Rectum 1,407 11.8 ±0.6 200 3.2 ±0.4 891 30.4 ±2.0 316 48.5 ±5.3
Pancreas 1,569 13.0 ±0.6 82 1.3 ±0.3 903 30.9 ±2.0 584 89.6 ±7.2
Other Gastrointestinal
Tract & Digestive System
2,185 17.7 ±0.7 132 2.1 ±0.4 1,466 50.1 ±2.5 587 90.1 ±7.2
Respiratory System &
Pleura
8,093 67.0 ±1.4 317 5.0 ±0.6 5,124 175.1 ±4.7 2,652 406.9 ±14.7
Larynx 448 3.6 ±0.3 35 0.6 ±0.2 329 11.2 ±1.2 84 12.9 ±2.8
Lung & Bronchus 7,538 62.4 ±1.4 257 4.1 ±0.5 4,743 162.1 ±4.5  2,538 389.4 ±14.4
Other Respiratory 107 0.9 ±0.2 25 0.4 ±0.2 52 1.8 ±0.5 30 4.6 ±1.6
Bones & Soft Tissue 428 3.9 ±0.4 148 2.3 ±0.4 188 6.4 ±0.9 92 14.1 ±2.9
Melanoma of Skin 2,107 18.7 ±0.8 484 7.7 ±0.7 1,120 38.3 ±2.2 502 77.0 ±6.7
Breast 7,763 66.8 ±1.5 1,402 22.2 ±1.2  4,764 162.8 ±4.5 1,597 245.0 ±11.7
Genitourinary Organs 14,223 117.2 ±1.9 1,315 20.8 ±1.1 9,644 329.5 ±6.3 3,264 500.8 ±16.1
Cervix Uteri 341 3.4 ±0.4 180 2.8 ±0.4 142 4.9 ±0.8 19 2.9 ±1.3
Corpus Uteri  1,779 14.4 ±0.7 174 2.8 ±0.4 1,306 44.6 ±2.4 299 45.9 ±5.2
Ovary 714 6.1 ±0.4 123 1.9 ±0.3 416 14.2 ±1.4 175 26.8 ±4.0
Prostate Gland 6,068 47.6 ±1.2 176 2.8 ±0.4 4,841 165.4 ±4.6  1,051 161.2 ±9.6
Other Genital 718 6.8 ±0.5 296 4.7 ±0.5 287 9.8 ±1.1 135 20.7 ±3.5
Urinary Bladder  2,555 21.4 ±0.8 90 1.4 ±0.3 1,357 46.4 ±2.5 1,108 170.0 ±9.8
Kidney and Renal Pelvis  1,924 16.4 ±0.7 271 4.3 ±0.5  1,227 41.9 ±2.3 426 65.4 ±6.2
Other Urinary 124 1.1 ±0.2 5 *   68 2.3 ±0.5 51 7.8 ±2.1
Brain & Other Central
Nervous System
662 6.1 ±0.5 225 3.6 ±0.5 310 10.6 ±1.2 127 19.5 ±3.4
Lymphomas 2,551 22.2 ±0.9 440 7.0 ±0.7  1,359 46.4 ±2.5 751 115.2 ±8.1
Hodgkin Lymphoma 261 2.6 ±0.3 160 2.5 ±0.4 76 2.6 ±0.6 25 3.8 ±1.5
Non-Hodgkin Lymphoma 2,290 19.7 ±0.8 280 4.4 ±0.5  1,283 43.8 ±2.4 726 111.4 ±8.0
Multiple Myeloma 732 6.1 ±0.4 42 0.7 ±0.2 454 15.5 ±1.4 236 36.2 ±4.6
Leukemias 1,471 12.9 ±0.6 261 4.1 ±0.5 719 24.6 ±1.8 491 75.3 ±6.6
All Other 3,679 32.9 ±1.1 852 13.5 ±0.9 1,802 61.6 ±2.8 1,025 157.3 ±9.4
Total 52,076 440.1 ±3.6 6,399 101.3 ±2.4 31,706 1,083.4 ±10.4 13,969 2,143.1 ±27.0
               

Notes: Age-Specific Rates are per 100,000 population in a specific age group. Age-Adjusted Rates are per 100,000 population. Age-adjusted rates are computed by the direct method, using as the standard population the age distribution of the total population of the United States for the year 2000. Adding and subtracting the number shown after the ± symbol from the rate creates a confidence interval indicating that the true rate lies between the lower and upper bounds of this interval with 95 % statistical confidence.
Case : A case is defined as a person with any newly diagnosed cancer with a behavior code of 3 (malignant primary site). Both in-situ and invasive urinary bladder cancer cases are included, in order to be consistent with SEER tabulations from the National Cancer Institute.
* : A rate is not calculated when there are fewer than 20 total events, or fewer than 6 events in an age category, because the width of the confidence interval would negate any usefulness for comparative purposes.
Source: Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2015. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services.
Last Updated: November 1, 2016